Immunotherapies for Hodgkin's lymphoma
- PMID: 18023356
- PMCID: PMC5792053
- DOI: 10.1016/j.critrevonc.2007.10.001
Immunotherapies for Hodgkin's lymphoma
Abstract
Multiple immune evasion strategies characterize the pathobiology of Hodgkin's lymphoma. These must be considered when developing and testing immunotherapeutic approaches for this disease. The clinical experience with adoptive immunotherapy of Epstein-Barr virus positive tumors, and with monoclonal antibodies directed against CD30, CD20, and other antigens, is herein reviewed.
Similar articles
-
Current treatment and immunotherapy of Hodgkin's lymphoma.Haematologica. 2005 Dec;90(12):1680-92. Haematologica. 2005. PMID: 16330443 Review.
-
Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model.Blood. 1996 Apr 1;87(7):2930-7. Blood. 1996. PMID: 8639913
-
Adoptive immunotherapy for Hodgkin's lymphoma.Int J Hematol. 2006 Jun;83(5):385-90. doi: 10.1532/IJH97.06107. Int J Hematol. 2006. PMID: 16787867 Review.
-
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.Int J Cancer. 1993 Jul 9;54(5):820-7. doi: 10.1002/ijc.2910540517. Int J Cancer. 1993. PMID: 7686889
-
CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.Int J Cancer. 1993 May 28;54(3):418-25. doi: 10.1002/ijc.2910540312. Int J Cancer. 1993. PMID: 8389737
Cited by
-
Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers.Front Oncol. 2012 Dec 17;2:194. doi: 10.3389/fonc.2012.00194. eCollection 2012. Front Oncol. 2012. PMID: 23251904 Free PMC article.
References
-
- Poppema S, van den Berg A. Interaction between host T cells and Reed–Sternberg cells in Hodgkin lymphomas. Semin Cancer Biol. 2000;10:345–50. - PubMed
-
- Marshall NA, Christie LE, Munro LR, et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood. 2004;103:1755–62. - PubMed
-
- Beck A, Pazolt D, Grabenbauer GG, et al. Expression of cytokine and chemokine genes in Epstein–Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease. J Pathol. 2001;194:145–51. - PubMed
-
- Poppema S, Potters M, Visser L, van den Berg AM. Immune escape mechanisms in Hodgkin's disease. Ann Oncol. 1998;9(Suppl 5):S21–4. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical